Suppr超能文献

多药耐药相关蛋白和P-糖蛋白介导的肝胆转运功能的体内成像

In vivo imaging of hepatobiliary transport function mediated by multidrug resistance associated protein and P-glycoprotein.

作者信息

Hendrikse N Harry, Kuipers Folkert, Meijer Coby, Havinga Rick, Bijleveld Charles M A, van der Graaf Winette T A, Vaalburg Willem, de Vries Elisabeth G E

机构信息

PET Center, University Hospital Groningen, The Netherlands.

出版信息

Cancer Chemother Pharmacol. 2004 Aug;54(2):131-8. doi: 10.1007/s00280-004-0793-2. Epub 2004 Apr 30.

Abstract

Multidrug resistance associated proteins (MRPs) and P-glycoprotein (P-gp) are involved in hepatobiliary transport of various compounds. Our aim was (1) to define transporter specificity of the cholescintigraphic agents 99mTc-HIDA and 99mTc-MIBI, which are used clinically for myocardial perfusion measurements; and (2) to deduce MRP and P-gp functions in vivo from hepatic 99mTc kinetics. Accumulation of radioactivity was measured in the human tumor cell lines GLC4, GLC4/ADR150x (MRP1-overexpressing/P-gp-negative) and GLC4/P-gp (P-gp-overexpressing). Bile secretion was quantified in untreated and in glutathione-depleted control and MRP2-deficient (GY/TR-) rats. Hepatobiliary transport was measured using a gamma camera in both types of rats. 99mTc-HIDA accumulated 5.8-fold less in GLC4/ADR150x calls than in GLC4 or GLC4/P-gp cells. In GLC4/ADR150x, the cellular 99mTc-HIDA content was increased 3.4-fold by the MRP1,2 inhibitor MK571 (50 microM), while MK571 had no measurable effect in GLC4 and GLC4/P-gp cells. 99mTc-MIBI accumulated less in GLC4/P-gp and GLC4/ADR150x cells than in GLC4 cells. Bile secretion of 99mTc-HIDA was impaired in GY/TR- compared to control rats and not affected by glutathione depletion in GY/TR- rats. Hepatic secretion of 99mTc-HIDA was slower in GY/TR- (t1/2 40 min) than in control rats (t1/2 7 min). Bile secretion of 99mTc-MIBI was similar in both rat strains and impaired by glutathione depletion in control rats only, indicating compensatory activity of additional transporter(s) in GY/TR- rats. 99mTc-HIDA is transported only by MRP1,2 only, while 99mTc-MIBI is transported by P-gp and MRP1,2. The results indicate that hepatic P-gp and MRP1,2 function can be assessed in vivo by sequential use of both radiopharmaceuticals.

摘要

多药耐药相关蛋白(MRP)和P-糖蛋白(P-gp)参与多种化合物的肝胆转运。我们的目的是:(1)确定临床上用于心肌灌注测量的胆闪烁造影剂99mTc-HIDA和99mTc-MIBI的转运体特异性;(2)从肝脏99mTc动力学推断体内MRP和P-gp的功能。在人肿瘤细胞系GLC4、GLC4/ADR150x(MRP1过表达/P-gp阴性)和GLC4/P-gp(P-gp过表达)中测量放射性的积累。在未处理的以及谷胱甘肽耗竭的对照大鼠和MRP2缺陷(GY/TR-)大鼠中对胆汁分泌进行定量。使用γ相机在两种类型的大鼠中测量肝胆转运。99mTc-HIDA在GLC4/ADR150x细胞中的积累比在GLC4或GLC4/P-gp细胞中少5.8倍。在GLC4/ADR150x中,MRP1,2抑制剂MK571(50 microM)使细胞内99mTc-HIDA含量增加了3.4倍,而MK571在GLC4和GLC4/P-gp细胞中没有可测量的影响。99mTc-MIBI在GLC4/P-gp和GLC4/ADR150x细胞中的积累比在GLC4细胞中少。与对照大鼠相比,99mTc-HIDA在GY/TR-大鼠中的胆汁分泌受损,并且不受GY/TR-大鼠中谷胱甘肽耗竭的影响。99mTc-HIDA在GY/TR-大鼠中的肝脏分泌(t1/2 40分钟)比对照大鼠(t1/2 7分钟)慢。99mTc-MIBI在两种大鼠品系中的胆汁分泌相似,仅在对照大鼠中因谷胱甘肽耗竭而受损,表明GY/TR-大鼠中存在其他转运体的代偿活性。99mTc-HIDA仅由MRP1,2转运,而99mTc-MIBI由P-gp和MRP1,2转运。结果表明,通过依次使用这两种放射性药物可以在体内评估肝脏P-gp和MRP1,2的功能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验